NEW
322Clinical trials
54EPA (Post authorization study)
5MD (Medical device study)
ACTIVE
1 377Clinical trials
278EPA (Post authorization study)
40MD (Medical device study)
224Clinical Trials on Rare Diseases
131Clinial Trials on Pediatrics
1 847Clinical Trials patient inclusions in 2020
Active Clinical Trials 5-year evolution
Patient inclusions 5-year evolution
Active Clinical Trials by Research Area
![Active Clinical Trials by Research Area](http://annualreport2020.vhir.org/wp-content/uploads/2021/09/08-clinical-trials-area-2020-82.jpg)
60ONCOLOGY
73VASCULAR BIOLOGY AND METABOLISM (VAM)
130NEUROSCIENCES
57INFECTIOUS DISEASES
59DIGESTIVE AND LIVER DISEASES
78IMMUNOMEDIATED DISEASES AND INNOVATIVE THERAPIES
29OBSTETRICS, PEDIATRICS AND GENETICS
10RESEARCH IN SURGERY
865ADULT ONCOLOGY & HEMATHOLOGY (VHIO)
16OTHERS
Billing evolution of clinical trials
2016 | 2017 | 2018 | 2019 | 2020 | |
Phase I-II | 8.59M€ | 9.51M€ | 10.76M€ | 12.64M€ | 12.36M€ |
Phase III | 5.91M€ | 6.20M€ | 9.12M€ | 8.25M€ | 9.05M€ |
Phase IV | 0.39M€ | 0.35M € | 0.21M€ | 0.14M€ | 0.19M€ |
EPA | 0.26M€ | 0.38M€ | 0.24M€ | 0.50M€ | 0.48M€ |
TOTAL | 15.15M€ | 16.44M€ | 20.33M€ | 21.52M€ | 22.08M€ |
Definitions & methodology
Data is at Campus level
The data includes commercial and academic studies that are registered in the database.
Research Area “Others”: studies of researchers who are not part of any research area of VHIR but belong to a Service of Vall d’Hebron Hospital.
New: studies with signed contract+AEMPS+CEIm.
Active: active+new+closed studies in the year.